Ora Bio Overview

  • Founded
  • 2005

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Ora Bio General Information


Developer of drugs designed to treat lung cancer. The company's drugs include two products such as the ORA101 for non-small cell lung cancer and ORA102 for age-related macular degeneration, enabling doctors to treat lung cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • P.O. Box 1252
  • Nazareth Illit 17000
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ora Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jan-2015 Completed Out of Business
1. Accelerator/Incubator 30-May-2006 Completed Startup
To view Ora Bio’s complete valuation and funding history, request access »

Ora Bio Executive Team (2)

Name Title Board Seat Contact Info
Josef Israeli Co-Founder & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Ora Bio Board Members (1)

Name Representing Role Since
Gary Jacobs Ora Bio Chairman 000 0000
To view Ora Bio’s complete board members history, request access »